Abstract PTH-095 Table 1
Survival rates
30 day
3 month
6 month
12 month
Colorectal cancer with liver metastases
93.75%
93.75%
68.75%
43.75%
Hepatocellular carcinoma
85.7%
71.4%
57.1%
42.9%
Neuroendocrine tumour with liver metastases
100%
100%
100%
100%